Yang Liu

8PUBLICATIONS
40CO-AUTHORS
Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 22, 2025
SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma.

Rudra Prasad Dutta, Heng-Huan Lee, Violetta V Leshchenko

|Nov 03, 2023
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins.

Yijing Li, Heng-Huan Lee, Vivian Changying Jiang

|Feb 16, 2023
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations.

Yuxuan Che, Yang Liu, Yixin Yao

|Nov 19, 2021
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma.

Preetesh Jain, Shuangtao Zhao, Hun Ju Lee

|May 10, 2019
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma.

Liang Zhang, Yixin Yao, Shaojun Zhang

Pageof 2

Frequent Collaborators

8 joint publications

Michael Wang

6 joint publications

Yixin Yao

3 joint publications

Holly A Hill

3 joint publications

Preetesh Jain